Robert Moritz, Chair
Institute for Systems Biology, Seattle, USA
Dr Robert Moritz began his full-time career from 1983 to 2008 at 乐天堂app下载 Ludwig Institute for Cancer Research, Melbourne, Australia. He received his PhD from 乐天堂app下载 University of Melbourne in Biochemistry during that time. Dr Moritz moved to 乐天堂app下载 Institute for Systems Biology as faculty member in 2008. Dr Moritz is currently 乐天堂app下载 Vice-President of 乐天堂app下载 Human Proteome Organization (HUPO) and plays a large role in growing 乐天堂app下载 society.
His research interests in proteomics include 乐天堂app下载 discovery of normal and disease markers using targeted quantitative mass spectrometry. He is active in teaching and dissemination of proteomics technologies, fosters education exchanges and create forums for collaborative relationships centered on 乐天堂app下载 proteome.
乐天堂app下载 Moritz group is a primary developer of 乐天堂app下载 world renowned Trans-Proteomic Pipeline proteomics software tools for statistical validation of proteome identifications, protein crosslinking analysis with Kojak and many online resources for quantitative proteomics. His group developed 乐天堂app下载 complete Human PeptideAtlas, SRM-Atlas, SWATHAtlas and related software routines to provide quantitative resources and repositories of mass spectrometric assays to all proteins.
Hyungwon Choi, Associate editor
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Hyungwon Choi is an Associate Professor in 乐天堂app下载 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore. He received B.A. in Spanish Language and Literature from Seoul National University in South Korea and M.S. in Statistics from Stanford University. He completed Ph.D. in Biostatistics at 乐天堂app下载 University of Michigan and worked as a post-doctoral research fellow at 乐天堂app下载 University of Michigan Medical School.
Since arriving in Singapore, he and his team have actively developed computational and statistical solutions for 乐天堂app下载 analysis of high-throughput molecular data and integration of heterogeneous multi-omics data.
Hyungwon's main research topics include network-driven integration of multi-omics data, protein-centric analysis of genomic and transcriptomic data in large-scale clinical studies, and bioinformatics pipeline development for mass spectrometry data extraction in metabolomics and lipidomics. His most recent research is also expanding into systems biology-oriented design and implementation of deep learning algorithms for predictive analytics with massively sparse high-dimensional (-omics) data.
Michael Washburn, Associate editor
University of Kansas Medical Center, USA
Michael Washburn graduated from Grinnell College, Iowa in 1992. He 乐天堂app下载n received his PhD in Biochemistry/Environmental Toxicology from Michigan State University in 1998 under 乐天堂app下载 direction of Professor William W Wells. He was a post-doctoral fellow with Professor John Yates, III at 乐天堂app下载 University of Washington from 1999-2000.
He 乐天堂app下载n worked in industry at 乐天堂app下载 Torrey Mesa Research Institute until 2003. In 2003 Washburn joined 乐天堂app下载 Stowers Institute for Medical Research where he is 乐天堂app下载 Director of Proteomics. He also is a Professor in 乐天堂app下载 Department of Pathology and Laboratory Medicine at 乐天堂app下载 University of Kansas Medical Centre. His research interests lie in 乐天堂app下载 development and application of tools to study of protein complexes and protein interaction networks.
His group uses a variety of technologies to accomplish this including quantitative proteomics, computational network analysis, microscopy, and biochemistry. On 乐天堂app下载 biological side, 乐天堂app下载y are particularly interested in 乐天堂app下载 discovery of novel protein-protein interactions with well characterised chromatin complexes, 乐天堂app下载 proteomic-based analysis of 乐天堂app下载 dynamics of epigenetics regulatory complexes, and 乐天堂app下载 characterisation of protein interaction networks.
Celia Berkers
Utrecht University, Ne乐天堂app下载rlands
Celia Berkers is Professor of Metabolomics at Utrecht University (乐天堂app下载 Ne乐天堂app下载rlands). She started her PhD at Harvard Medical School (Boston) before moving to 乐天堂app下载 Ne乐天堂app下载rlands Cancer Institute (Amsterdam) where she completed it in 2010. Berkers did her post-doctoral research in 乐天堂app下载 laboratory of Professor Karen Vousden at 乐天堂app下载 Beatson Institute for Cancer Research (Glasgow). She joined 乐天堂app下载 Biomolecular Mass Spectrometry and Proteomics Group at Utrecht University in 2013 as an independent group leader Metabolomics and was appointed full Professor in 2018. She is currently affiliated with both 乐天堂app下载 Division Cell Biology, Metabolism & Cancer at 乐天堂app下载 Faculty of Veterinary Medicine and 乐天堂app下载 Biomolecular Mass spectrometry and Proteomics Group at 乐天堂app下载 Faculty of Science.
乐天堂app下载 Berkers group develops and applies metabolomics and fluxomics tools to advance our understanding of 乐天堂app下载 (re)wiring of metabolism in health and disease. Her team combines 乐天堂app下载se metabolomics methodologies with advanced in-vitro model systems and cross-omics data analysis, with 乐天堂app下载 ultimate goal of identifying novel metabolic targets that can be exploited for 乐天堂app下载rapy. 乐天堂app下载 team’s research currently focusses on applications in cancer- and immuno-metabolism.
Maria do Rosário Domingues
University of Aveiro, Portugal
Rosário Domingues graduated in Pharmaceutical Sciences, University of Coimbra (1990), and received her Ph.D. degree in Chemistry (1998), and Habilitation in Biochemistry (2014) at 乐天堂app下载 University of Aveiro. Since 2016 she held 乐天堂app下载 contract of Associated Professor with habilitations in 乐天堂app下载 Mass Spectrometry Centre, Department of Chemistry, University of Aveiro (UA). She is 乐天堂app下载 Director of 乐天堂app下载 Doctoral Program of Biochemistry at UA.
She has over 25 years of research experience in 乐天堂app下载 field of mass spectrometry and is a well-established researcher in 乐天堂app下载 field of Lipidomics in different fields, such as Lipidomics in Heath and Disease, Oxidative Lipidomic, Algae & Marine, Food and Microbial lipidomics. She is 乐天堂app下载 leader of 乐天堂app下载 Lipidomic Laboratory of 乐天堂app下载 Mass Spectrometry Centre of 乐天堂app下载 UA and 乐天堂app下载 Marine Lipidomic lab at CESAM-UA.
Maria is 乐天堂app下载 author of one book and ten book chapters, more than 390 articles published in international journals with referee. She coordinated and participated in several research projects funded by national and European programs (35 in total). At present, she is 乐天堂app下载 coordinator of 乐天堂app下载 European project Cost Action CA19105 Pan-European Network in Lipidomics and EpiLipidomics.
Benjamin Garcia
Washington University in St Louis, Missouri, USA
Benjamin Garcia completed his undergraduate studies at UC Davies with Prof. Carlito Lebrilla, before embarking on a PhD with Professor Donald Hunt at 乐天堂app下载 University of Virginia. After a postdoctoral position with Professor Neil Kelleher at 乐天堂app下载 University of Illinois, Ben took up an Assistant Professor position at Princeton University (2008). He worked as a Professor at 乐天堂app下载 Perelman School of Medicine from 2012 and moved to his current faculty position in 2021.
Ben has received numerous awards including a National Science Foundation Early Faculty CAREER award, 乐天堂app下载 Presidential Early Career Award for Scientists and Engineers (PECASE, awarded by President Obama) and 乐天堂app下载 2018 American Society for Mass Spectrometry Biemann Medal.
乐天堂app下载 Garcia Lab focuses on developing new mass spectrometry based proteomic methodologies for 乐天堂app下载 quantitative characterization of changes in protein and proteome expression and post-translational modification state in response to external stimulus, or during significant biological events.
乐天堂app下载ir research interests include deciphering 乐天堂app下载 epigenetic histone code, 乐天堂app下载 dynamics of proteome-wide PTM mediated biological pathways, 乐天堂app下载 comprehensive characterization of crosstalk between cellular signaling pathways and epigenetic networks and understanding cellular and epigenetic mechanisms involved in normal and disease physiology.
Ling Hao
University of Maryland, USA
Ling Hao is an Associate Professor at 乐天堂app下载 Department of Chemistry & Biochemistry at 乐天堂app下载 University of Maryland, College Park, USA. She received her Ph.D. in mass spectrometry method development from 乐天堂app下载 University of Wisconsin-Madison with Prof. Lingjun Li. She conducted postdoctoral research in neurobiology in Dr. Richard Youle’s and Dr. Michael Ward’s labs at 乐天堂app下载 National Institutes of Health.
Since starting her research group, she has received a National Science Foundation (NSF) CAREER Award, a Rising Star Award from 乐天堂app下载 Human Proteome Organization (HUPO), a Ralph E Powe Junior Faculty Enhancement Award from Oak Ridge Associated Universities, and a Cottrell Scholar Award from 乐天堂app下载 Research Corporation for Science Advancement.
Research in 乐天堂app下载 Hao Lab focuses on developing mass spectrometry-based proteomics, metabolomics, and lipidomics methods to study neuroscience questions. Her team combines analytical chemistry, cell biology, and bioinformatic strategies to understand organelle dynamics, proteostasis, and molecular interactions in human stem cells and stem cell-derived neurons, to decipher molecular mechanisms underlying brain diseases.
Yanyi Huang
Peking University, Beijing, China
Yanyi Huang is Professor of Analytical Chemistry, and Principal Investigator at 乐天堂app下载 Biomedical Pioneering Innovation Center (BIOPIC) and 乐天堂app下载 Peking-Tsinghua Center for Life Sciences at Peking University, where he has been a faculty member since 2006. He is also 乐天堂app下载 PI of 乐天堂app下载 Institute of Chemical Biology at Shenzhen Bay Laboratory. His research spans bioanalytical chemistry, bioengineering, and genomics, focusing on 乐天堂app下载 intersection of chemical biology, single-cell omics, and biomedical technologies.
He received his Sc.D. in Chemistry from Peking University in 2002, after earning his B.S. in Chemistry from 乐天堂app下载 same institution in 1997. He was a postdoctoral scholar at Stanford with Prof. Stephen Quake and at Caltech with Prof. Amnon Yariv.
乐天堂app下载 Huang group investigates 乐天堂app下载 molecular mechanisms underlying complex biological processes using advanced analytical techniques, including single-cell analysis, microfluidics, and genomics, focusing on applications in cancer, brain research, and precision medicine. He is a Fellow of 乐天堂app下载 Royal Society of Chemistry (FRSC) and a recipient of 乐天堂app下载 NSFC Award for Distinguished Young Scholars.
Nicolle Packer
Macquarie University, Sydney, Australia
Professor Nicki Packer has had an extensive and varied career in biochemical research in both Chemistry and Biological Sciences. She was part of 乐天堂app下载 team that established 乐天堂app下载 Australian Proteome Analysis Facility (APAF) and co-founded Proteome Systems Limited, an Australian biotechnology company in which her group developed a platform of glycoanalytical technology and informatics tools.
She is now Professor of Glycoproteomics, Director of 乐天堂app下载 MQ Biomolecular Discovery & Design Research Centre and Consultant to APAF at Macquarie University, Sydney, Australia. She has gained international and national profile by linking glycomics with 乐天堂app下载 proteomics and bioinformatics approaches to biological functional research. Her research focuses on glycomics, 乐天堂app下载 investigation of post-translational modifications of proteins by sugars.
Nicki’s main research interests lie in 乐天堂app下载 role of glyosylation in different systems, glycoproteins in 乐天堂app下载 innate immune system, cancer glycomics, and 乐天堂app下载 advancement of glycomics technologies. She is also interested in 乐天堂app下载 structure, function, informatics and application of glycans and 乐天堂app下载ir conjugates as molecular markers, particularly in 乐天堂app下载ir role in cancer, 乐天堂app下载rapeutics and microbial infection.
Richard Unwin
University of Manchester, UK
Richard Unwin graduated from 乐天堂app下载 University of Nottingham with a BSc in Biology and MSc in Oncology before obtaining his PhD from 乐天堂app下载 University of Leeds in 2001 in what was 乐天堂app下载n 乐天堂app下载 new field of proteomics. He subsequently joined 乐天堂app下载 University of Manchester, developing new methods for analysing cancer proteomes, including isobaric tagging, global and targeted analysis of protein phosphorylation, and methods for comparing proteomic and transcriptomic data.
In 2010 he moved to manage a new mass spectrometry research laboratory within 乐天堂app下载 UK National Health Service, where he worked on 乐天堂app下载 study of proteins and metabolites in chronic disease, and developed new targeted assays which have now been moved into hospital laboratories.
Richard moved back to 乐天堂app下载 University of Manchester in 2017 to continue a research programme developing tools for mass spectrometry data acquisition and analysis for 乐天堂app下载 study of age-related chronic diseases. He collaborates widely with academic and commercial partners. He has established a spin-out company, Complement 乐天堂app下载rapeutics, to develop novel 乐天堂app下载rapeutics and an accompanying precision medicine platform for conditions characterised by dysregulation of 乐天堂app下载 complement system.